AU2820495A - G-protein receptor htnad29 - Google Patents

G-protein receptor htnad29

Info

Publication number
AU2820495A
AU2820495A AU28204/95A AU2820495A AU2820495A AU 2820495 A AU2820495 A AU 2820495A AU 28204/95 A AU28204/95 A AU 28204/95A AU 2820495 A AU2820495 A AU 2820495A AU 2820495 A AU2820495 A AU 2820495A
Authority
AU
Australia
Prior art keywords
htnad29
protein receptor
receptor
protein
receptor htnad29
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU28204/95A
Other versions
AU714642B2 (en
Inventor
Rebecca A Fuldner
Yi Li
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of AU2820495A publication Critical patent/AU2820495A/en
Application granted granted Critical
Publication of AU714642B2 publication Critical patent/AU714642B2/en
Priority to AU26430/00A priority Critical patent/AU760468B2/en
Priority to AU2003235001A priority patent/AU2003235001A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Physics & Mathematics (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Plant Pathology (AREA)
AU28204/95A 1995-06-06 1995-06-06 G-protein receptor HTNAD29 Ceased AU714642B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU26430/00A AU760468B2 (en) 1995-06-06 2000-04-06 G-protein receptor HTNAD29
AU2003235001A AU2003235001A1 (en) 1995-06-06 2003-08-14 G-Protein Receptor HTNAD29

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1995/007288 WO1996039442A1 (en) 1995-06-06 1995-06-06 G-protein receptor htnad29

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU26430/00A Division AU760468B2 (en) 1995-06-06 2000-04-06 G-protein receptor HTNAD29

Publications (2)

Publication Number Publication Date
AU2820495A true AU2820495A (en) 1996-12-24
AU714642B2 AU714642B2 (en) 2000-01-06

Family

ID=22249278

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28204/95A Ceased AU714642B2 (en) 1995-06-06 1995-06-06 G-protein receptor HTNAD29

Country Status (7)

Country Link
EP (1) EP0832126A4 (en)
JP (1) JPH11506341A (en)
KR (1) KR19990022531A (en)
CN (1) CN1147505C (en)
AU (1) AU714642B2 (en)
CA (1) CA2221706A1 (en)
WO (1) WO1996039442A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6221627B1 (en) * 1997-02-24 2001-04-24 Smithkline Beecham Corporation cDNA clone HDPB130 that encodes a novel human 7-transmembrane receptor
US6555339B1 (en) * 1997-04-14 2003-04-29 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human protein-coupled receptors
EP2264068A1 (en) * 1998-10-13 2010-12-22 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human G protein-coupled receptors
ES2272309T3 (en) 1999-08-03 2007-05-01 Millennium Pharmaceuticals, Inc. 15571, A NEW GPCR TYPE MOLECULA OF THE SECRETINE TYPE FAMILY AND ITS USES.
US6919176B2 (en) 2001-05-07 2005-07-19 Amgen Inc. Polypeptides and nucleic acids associated with cancer
AU2003206749A1 (en) * 2002-02-01 2003-09-02 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with the gpr65 receptor
WO2004112823A1 (en) 2003-06-20 2004-12-29 Novartis Ag Proton-sensing g-protein coupled receptors and dna sequences thereof
WO2008101354A1 (en) * 2007-02-22 2008-08-28 Merck Frosst Canada Ltd Gpr65 as a therapeutic target in allergic airway inflammation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262529A (en) * 1990-01-24 1993-11-16 President And Fellows Of Harvard College Diagnosis of hereditary retinal degenerative diseases
US5462856A (en) * 1990-07-19 1995-10-31 Bunsen Rush Laboratories, Inc. Methods for identifying chemicals that act as agonists or antagonists for receptors and other proteins involved in signal transduction via pathways that utilize G-proteins
EP0668930B1 (en) * 1991-10-01 2002-12-18 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES A method of identifying ligands and antagonists of ligands
US5508384A (en) * 1992-09-10 1996-04-16 New York University Polypeptide derived from a popamine receptor, and compositions and methods thereof
US6066322A (en) * 1995-03-03 2000-05-23 Millennium Pharmaceuticals, Inc. Methods for the treatment of immune disorders

Also Published As

Publication number Publication date
WO1996039442A1 (en) 1996-12-12
KR19990022531A (en) 1999-03-25
CN1193980A (en) 1998-09-23
JPH11506341A (en) 1999-06-08
AU714642B2 (en) 2000-01-06
EP0832126A4 (en) 2000-01-12
EP0832126A1 (en) 1998-04-01
CA2221706A1 (en) 1996-12-12
CN1147505C (en) 2004-04-28

Similar Documents

Publication Publication Date Title
AU7692996A (en) Receptor antagonists
AU4803996A (en) Endothelin receptor antagonists
AU2663295A (en) Human g-protein chemokine receptor hdgnr10
AU7694496A (en) Endothelin receptor antagonists
AU2766395A (en) Human g-protein receptor hgber32
AU2236895A (en) Human g-protein coupled receptors
AU5196996A (en) Adhesion receptor antagonists
AU6679296A (en) Hepadnavirus receptor
AU7132898A (en) Edg-1-like receptor
AU1550195A (en) G-protein coupled receptor
AU6748196A (en) Receptor
AU2662695A (en) Human g-protein receptor hpraj70
AU6961796A (en) Improved interleukin-6 receptor antagonist
AU2820495A (en) G-protein receptor htnad29
AU8921198A (en) New human g-protein coupled receptor
AU6764596A (en) Endothelin receptor antagonists
AU6060796A (en) Endothelin receptor antagonists
AU4898496A (en) Human g-protein chemokine receptor hsatu68
AU4753496A (en) Human g-protein coupled receptor
AU2663495A (en) Human g-protein receptor hcegh45
AU4446296A (en) Adhesion receptor antagonists
AU6079296A (en) Endothelin receptor antagonists
AUPO938697A0 (en) Novel receptor
AU2698995A (en) G-protein receptor hibeb69
AU1921695A (en) Human g-protein coupled receptor

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)